Your browser doesn't support javascript.
loading
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher, Nick; Hirsch, Fred R; Luft, Alexander V; Szczesna, Aleksandra; Ciuleanu, Tudor E; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K; Bálint, Beatrix; Losonczy, György; Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Kruljac-Letunic, Anamarija; Kurek, Raffael; Paz-Ares, Luis; Socinski, Mark A.
Afiliación
  • Thatcher N; The Christie Hospital, Manchester, UK. Electronic address: nick.thatcher@christie.nhs.uk.
  • Hirsch FR; University of Colorado Cancer Center, Aurora, CO, USA.
  • Luft AV; Leningrad Regional Clinical Hospital, St Petersburg, Russia.
  • Szczesna A; Regional Lung Disease Hospital, Otwock, Poland.
  • Ciuleanu TE; Institutul Oncologic Prof Dr Ion Chiricuta and UMF Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Dediu M; Institute of Oncology, Bucharest, Romania.
  • Ramlau R; Poznan University of Medical Sciences, Poznan, Poland.
  • Galiulin RK; Omsk Regional Oncology Center, Omsk, Russia.
  • Bálint B; Csongrád County Hospital of Chest Diseases, Deszk, Hungary.
  • Losonczy G; Semmelweis University Department of Pulmonology, Budapest, Hungary.
  • Kazarnowicz A; Tuberculosis and Lung Disease Hospital, Olsztyn, Poland.
  • Park K; Samsung Medical Center, Seoul, South Korea.
  • Schumann C; Department of Internal Medicine II, University Hospital of Ulm, Ulm, Germany; Clinic for Pneumology, Thoracic Oncology, Sleep- and Respiratory Critical Care, Kempten-Oberallgaeu Hospitals, Kempten, Germany.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Depenbrock H; Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Nanda S; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Kruljac-Letunic A; Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Kurek R; Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Paz-Ares L; Instituto de Biomedicina de Sevilla - IBIS (Hospital Virgen del Rocío, Universidad de Sevilla & CSIC), Seville, Spain.
  • Socinski MA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Lancet Oncol ; 16(7): 763-74, 2015 Jul.
Article en En | MEDLINE | ID: mdl-26045340
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article